<DOC>
	<DOCNO>NCT00344110</DOCNO>
	<brief_summary>Assessing efficacy , safety pharmacokinetics patient mild moderate essential hypertension</brief_summary>
	<brief_title>Study Comparing SPP100 ( Aliskiren ) 150mg Placebo Losartan 50mg Patients With Mild Moderate Essential Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Age : 20 75 year old Gender : Male female Status : Outpatients Mild moderate essential hypertension Pregnant woman , lactate mother , woman suspect pregnant , woman wish pregnant Patients msSBP &gt; ==180 mmHg and/or msDBP &gt; =110 mmHg Visit 1 , 2 3 Patients suspect secondary hypertension ( due aortic coarctation , primary aldosteronism , etc . ) Patients suspect malignant hypertension Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Hypertension , aliskiren , blood pressure , renin</keyword>
</DOC>